Widely read:
Apollo Hospitals Enterprise, India’s leading private healthcare provider, is set to announce its fourth-quarter financial results for fiscal year 2024–25 on May 30, 2025. The past year has been marked by steady growth, operational efficiency, and strategic investments in expanding its hospital network and digital health services — all of which investors and healthcare observers will closely watch in the upcoming results.
Recent quarterly performance highlights
- Q3 FY25: Apollo Hospitals reported an impressive 52 per cent year-on-year increase in consolidated net profit. This strong performance was driven by rising patient volumes, enhanced speciality care services, and improved operational efficiency.
- Q2 FY25: The company recorded approximately 30 per cent growth in net profit compared to the previous year. Margin improvement initiatives and growing demand across its hospitals and diagnostics divisions contributed significantly to the company's performance.
- Q1 FY25: Despite macroeconomic challenges, Apollo sustained a positive trajectory with around 17 per cent revenue growth. Higher average revenue per patient and cost controls contributed to improved profitability.
What to expect from Q4 FY25 results?
Analysts anticipate Apollo Hospitals to maintain its growth momentum, fueled by increasing healthcare demand and ongoing expansion projects. Key aspects to watch include:
- Revenue and profit growth: Continuation of the strong upward trend in patient footfall, speciality care, and diagnostics revenue.
- Operating margins: Ability to manage inflationary pressures and increased investments while sustaining profitability.
- Expansion updates: Progress on adding 2,300 hospital beds over the next three years, backed by an estimated Rs 3,400 crore capital expenditure.
- Digital health contribution: Growth in Apollo’s telemedicine, home healthcare, and diagnostics platforms, which are increasingly integral to its business model.
Stock ratings from Value Research Online
As of May 27, 2025, Value Research Online provides the following ratings for Apollo Hospitals Enterprise Ltd., scored on a scale from 1 to 10 (higher is better):
- Quality Score: 5/10 — Reflecting moderate financial health and operational stability.
- Growth Score: 7/10 — Signifying consistent revenue and earnings growth over recent years.
- Valuation Score: 3/10 — Indicating the stock is trading at a premium relative to fundamentals.
- Momentum Score: 7/10 — Demonstrating positive stock price movement supported by steady investor interest.
These ratings highlight Apollo Hospitals’ solid fundamentals and growth prospects, while suggesting a cautious approach given the current valuation levels.
Key financials at a glance
- Market capitalisation stands at Rs 1,01,396 crore.
- Trailing twelve months (TTM) revenue is approximately Rs 21,146 crore, with net profit of Rs 1,310 crore.
- The Return on Equity (ROE) is 14.3 per cent, and the Return on Capital Employed (ROCE) is 19.1 per cent, reflecting efficient capital utilisation.
- The Price-to-Earnings (P/E) ratio is relatively high at 77.4, indicating elevated market expectations.
Why this matters to healthcare investors and watchers
Apollo Hospitals is a bellwether for the Indian healthcare sector, often reflecting broader industry trends. Its performance signals increasing healthcare accessibility and rising patient demand in India. Moreover, its investments in digital health initiatives, such as telemedicine and home care, represent a shift toward more convenient and technology-driven healthcare delivery.
As Apollo releases its Q4 FY25 results, stakeholders will be keen to gauge its ability to sustain growth, manage rising costs, and execute its expansion plans in an increasingly competitive environment.
For detailed financial information, visit our stock page- Apollo Hospitals
Disclaimer: This article was written with the assistance of artificial intelligence. While our digital writer has been trained to follow our editorial style, we recommend applying a critical eye while reading. Enjoy the story — and keep smiling with understanding!
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
New episodes every Friday 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
